Free COVID-19 STAT Intelligence Briefings Email Digest

Subscribe Now!
Linkedin
Twitter

COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

  • Home
  • Briefings
  • Regulation
  • Webinars
  • Live Calls
  • Testing Data
  • COVID-19 Resources
  • Mission
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Live Calls
  • Testing Data
  • COVID-19 Resources
  • Mission

Free COVID-19 STAT Intelligence Briefings Email Digest

Subscribe Now!
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Live Calls
  • Testing Data
  • COVID-19 Resources
  • Mission
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Live Calls
  • Testing Data
  • COVID-19 Resources
  • Mission
Linkedin
Twitter

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Author: The Dark Intelligence Group

New Administration Creates COVID-19 Pandemic Testing Board to Coordinate National Testing Efforts

COVID-19 pandemic testing board creation

Creation of COVID-19 Pandemic Testing Board may affect clinical laboratories and lead to a change in national COVID-19 testing.

University Develops Successful COVID-19 LDT in Six Weeks by Focusing on the Benefits of Saliva Test

Insights into University of Illinois’ COVID-19 testing program using saliva test offer perspective on COVID-19 testing for universities.

CMS Releases New Surveyor Guidance Outlining Process of Evaluating SARS-CoV-2 Test Reporting Requirements

look at transparency in pricing COVID-19 testing, clinical laboratories

Thirty-one pages of new CMS guidance distilled into 10 probing questions revealing what CMS surveyors will be looking for in clinical laboratories, with regard to their COVID-19 testing tracing and reporting.

Viral Load Can Predict COVID-19 Severity Only in Saliva Specimens, New Study Shows

concept of coinfections and covid

Summary of new research into viral load with SARS-CoV-2.

New COVID-19 Travel Testing Order Set to Go into Effect Jan. 26

CDC orders airlines to verify and confirm documentation for SARS-CoV-2 COVID-19 negative test

Summary of new Centers for Disease Control and Prevention (CDC) order affecting COVID-19 testing for all passengers from foreign countries.

FDA Issues Safety Communication Warning of Potential False Negatives with Curative SARS-Cov-2 Test

FDA maze of regulations

Curative SARS-Cov-2 diagnosis test providing high number of false negatives, FDA warns.

FDA Issues Alert to Clinical Laboratories About the Effects of New SARS-CoV-2 Variant on Testing

FDA maze of regulations

A new SARS-CoV-2 variant, B.1.1.7, was identified late last year in the UK, prompting the FDA to monitor existing tests, such as TaqPath, Linea, and Accula.

HHS Announces $22 Billion for COVID-19 Testing and Monitoring

national-testing-strategy-SARS-CoV-2-coalition

HHS details state-level support for COVID-19 testing and monitoring, with the more than $19 billion to be allocated through the existing CDC ELC cooperative agreement.

One Clinical Laboratory Now Offering Its COVID-19 Diagnostic Test On Amazon

amazon delivers covid19 tests now

While diagnostic testing for COVID-19 slowly shifts away from clinical laboratories, these changes can be beneficial.

CDC Announces New COVID-19 Testing Requirement for Travelers Arriving from the UK

CDC orders airlines to verify and confirm documentation for SARS-CoV-2 COVID-19 negative test

US Centers for Disease Control and Prevention orders airlines to verify and confirm documentation for COVID-19 negative testing for certain travelers.

← older
More COVID-19 Coverage Can Be Found in THE DARK REPORT
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Live Calls
  • Testing Data
  • COVID-19 Resources
  • Mission
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Live Calls
  • Testing Data
  • COVID-19 Resources
  • Mission

Copyright 2020 © The Dark Report. All rights reserved. The Dark Intelligence Group • 21806 Briarcliff Dr • Spicewood, TX 78669

  • Phone: 512-264-7103
Linkedin
Twitter